Takeda Pharmaceuticals Faces Trial Over Anti-Gout Drug Antitrust Allegations
A refusal by a Pennsylvania federal court to diminish claims from a lawsuit against Takeda Pharmaceuticals and a number of generic-drug makers denotes an escalating issue concerning alleged anti-competitive behavior. These pharmaceutical companies have been accused of striking up exclusivity contracts aiming to delay competition for Takeda’s anti-gout drug, Colcrys. As a result, this controversial…